Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Overt Hepatic Encephalopathy Market Size Growth Rate by Type (2014-2025) 1.4.2 Covert 1.4.3 Overt 1.5 Market by Application 1.5.1 Global Overt Hepatic Encephalopathy Market Share by Application (2014-2025) 1.5.2 Hospitals 1.5.3 Research Institutes 1.5.4 Clinics 1.5.5 Surgical Centers 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Overt Hepatic Encephalopathy Market Size 2.2 Overt Hepatic Encephalopathy Growth Trends by Regions 2.2.1 Overt Hepatic Encephalopathy Market Size by Regions (2014-2025) 2.2.2 Overt Hepatic Encephalopathy Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Overt Hepatic Encephalopathy Market Size by Manufacturers 3.1.1 Global Overt Hepatic Encephalopathy Revenue by Manufacturers (2014-2019) 3.1.2 Global Overt Hepatic Encephalopathy Revenue Market Share by Manufacturers (2014-2019) 3.1.3 Global Overt Hepatic Encephalopathy Market Concentration Ratio (CR5 and HHI) 3.2 Overt Hepatic Encephalopathy Key Players Head office and Area Served 3.3 Key Players Overt Hepatic Encephalopathy Product/Solution/Service 3.4 Date of Enter into Overt Hepatic Encephalopathy Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Overt Hepatic Encephalopathy Market Size by Type (2014-2019) 4.2 Global Overt Hepatic Encephalopathy Market Size by Application (2014-2019) 5 United States 5.1 United States Overt Hepatic Encephalopathy Market Size (2014-2019) 5.2 Overt Hepatic Encephalopathy Key Players in United States 5.3 United States Overt Hepatic Encephalopathy Market Size by Type 5.4 United States Overt Hepatic Encephalopathy Market Size by Application 6 Europe 6.1 Europe Overt Hepatic Encephalopathy Market Size (2014-2019) 6.2 Overt Hepatic Encephalopathy Key Players in Europe 6.3 Europe Overt Hepatic Encephalopathy Market Size by Type 6.4 Europe Overt Hepatic Encephalopathy Market Size by Application 7 China 7.1 China Overt Hepatic Encephalopathy Market Size (2014-2019) 7.2 Overt Hepatic Encephalopathy Key Players in China 7.3 China Overt Hepatic Encephalopathy Market Size by Type 7.4 China Overt Hepatic Encephalopathy Market Size by Application 8 Japan 8.1 Japan Overt Hepatic Encephalopathy Market Size (2014-2019) 8.2 Overt Hepatic Encephalopathy Key Players in Japan 8.3 Japan Overt Hepatic Encephalopathy Market Size by Type 8.4 Japan Overt Hepatic Encephalopathy Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Overt Hepatic Encephalopathy Market Size (2014-2019) 9.2 Overt Hepatic Encephalopathy Key Players in Southeast Asia 9.3 Southeast Asia Overt Hepatic Encephalopathy Market Size by Type 9.4 Southeast Asia Overt Hepatic Encephalopathy Market Size by Application 10 India 10.1 India Overt Hepatic Encephalopathy Market Size (2014-2019) 10.2 Overt Hepatic Encephalopathy Key Players in India 10.3 India Overt Hepatic Encephalopathy Market Size by Type 10.4 India Overt Hepatic Encephalopathy Market Size by Application 11 Central & South America 11.1 Central & South America Overt Hepatic Encephalopathy Market Size (2014-2019) 11.2 Overt Hepatic Encephalopathy Key Players in Central & South America 11.3 Central & South America Overt Hepatic Encephalopathy Market Size by Type 11.4 Central & South America Overt Hepatic Encephalopathy Market Size by Application 12 International Players Profiles 12.1 Alfa Wassermann 12.1.1 Alfa Wassermann Company Details 12.1.2 Company Description and Business Overview 12.1.3 Overt Hepatic Encephalopathy Introduction 12.1.4 Alfa Wassermann Revenue in Overt Hepatic Encephalopathy Business (2014-2019) 12.1.5 Alfa Wassermann Recent Development 12.2 Cosmo Pharmaceuticals 12.2.1 Cosmo Pharmaceuticals Company Details 12.2.2 Company Description and Business Overview 12.2.3 Overt Hepatic Encephalopathy Introduction 12.2.4 Cosmo Pharmaceuticals Revenue in Overt Hepatic Encephalopathy Business (2014-2019) 12.2.5 Cosmo Pharmaceuticals Recent Development 12.3 Horizon Pharma 12.3.1 Horizon Pharma Company Details 12.3.2 Company Description and Business Overview 12.3.3 Overt Hepatic Encephalopathy Introduction 12.3.4 Horizon Pharma Revenue in Overt Hepatic Encephalopathy Business (2014-2019) 12.3.5 Horizon Pharma Recent Development 12.4 KannaLife Sciences 12.4.1 KannaLife Sciences Company Details 12.4.2 Company Description and Business Overview 12.4.3 Overt Hepatic Encephalopathy Introduction 12.4.4 KannaLife Sciences Revenue in Overt Hepatic Encephalopathy Business (2014-2019) 12.4.5 KannaLife Sciences Recent Development 12.5 Ocer Therapeutics 12.5.1 Ocer Therapeutics Company Details 12.5.2 Company Description and Business Overview 12.5.3 Overt Hepatic Encephalopathy Introduction 12.5.4 Ocer Therapeutics Revenue in Overt Hepatic Encephalopathy Business (2014-2019) 12.5.5 Ocer Therapeutics Recent Development 12.6 Rebiotix 12.6.1 Rebiotix Company Details 12.6.2 Company Description and Business Overview 12.6.3 Overt Hepatic Encephalopathy Introduction 12.6.4 Rebiotix Revenue in Overt Hepatic Encephalopathy Business (2014-2019) 12.6.5 Rebiotix Recent Development 12.7 Spherium Biomed 12.7.1 Spherium Biomed Company Details 12.7.2 Company Description and Business Overview 12.7.3 Overt Hepatic Encephalopathy Introduction 12.7.4 Spherium Biomed Revenue in Overt Hepatic Encephalopathy Business (2014-2019) 12.7.5 Spherium Biomed Recent Development 12.8 Umecrine Cognition 12.8.1 Umecrine Cognition Company Details 12.8.2 Company Description and Business Overview 12.8.3 Overt Hepatic Encephalopathy Introduction 12.8.4 Umecrine Cognition Revenue in Overt Hepatic Encephalopathy Business (2014-2019) 12.8.5 Umecrine Cognition Recent Development 12.9 ASKA Pharmaceutical 12.9.1 ASKA Pharmaceutical Company Details 12.9.2 Company Description and Business Overview 12.9.3 Overt Hepatic Encephalopathy Introduction 12.9.4 ASKA Pharmaceutical Revenue in Overt Hepatic Encephalopathy Business (2014-2019) 12.9.5 ASKA Pharmaceutical Recent Development 12.10 Mallinckrodt 12.10.1 Mallinckrodt Company Details 12.10.2 Company Description and Business Overview 12.10.3 Overt Hepatic Encephalopathy Introduction 12.10.4 Mallinckrodt Revenue in Overt Hepatic Encephalopathy Business (2014-2019) 12.10.5 Mallinckrodt Recent Development 12.11 Valeant 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2019-2025) 13.10 Market Size Forecast by Application (2019-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table Overt Hepatic Encephalopathy Key Market Segments Table Key Players Overt Hepatic Encephalopathy Covered Table Global Overt Hepatic Encephalopathy Market Size Growth Rate by Type 2014-2025 (Million US$) Figure Global Overt Hepatic Encephalopathy Market Size Market Share by Type 2014-2025 Figure Covert Figures Table Key Players of Covert Figure Overt Figures Table Key Players of Overt Table Global Overt Hepatic Encephalopathy Market Size Growth by Application 2014-2025 (Million US$) Figure Hospitals Case Studies Figure Research Institutes Case Studies Figure Clinics Case Studies Figure Surgical Centers Case Studies Figure Overt Hepatic Encephalopathy Report Years Considered Table Global Overt Hepatic Encephalopathy Market Size 2014-2025 (Million US$) Figure Global Overt Hepatic Encephalopathy Market Size and Growth Rate 2014-2025 (Million US$) Table Global Overt Hepatic Encephalopathy Market Size by Regions 2014-2025 (Million US$) Table Global Overt Hepatic Encephalopathy Market Size by Regions 2014-2019 (Million US$) Table Global Overt Hepatic Encephalopathy Market Share by Regions 2014-2019 Figure Global Overt Hepatic Encephalopathy Market Share by Regions 2014-2019 Figure Global Overt Hepatic Encephalopathy Market Share by Regions 2019 Table Market Top Trends Table Global Overt Hepatic Encephalopathy Revenue by Manufacturers (2014-2019) (Million US$) Table Global Overt Hepatic Encephalopathy Market Share by Manufacturers (2014-2019) Figure Global Overt Hepatic Encephalopathy Market Share by Manufacturers in 2018 Table Global Overt Hepatic Encephalopathy Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Overt Hepatic Encephalopathy Product/Solution/Service Table Date of Enter into Overt Hepatic Encephalopathy Market Table Mergers & Acquisitions, Expansion Plans Table Global Overt Hepatic Encephalopathy Market Size by Type (2014-2019) (Million US$) Table Global Overt Hepatic Encephalopathy Market Size Share by Type (2014-2019) Figure Global Overt Hepatic Encephalopathy Market Size Market Share by Type (2014-2019) Table Global Overt Hepatic Encephalopathy Market Size by Application (2014-2019) (Million US$) Table Global Overt Hepatic Encephalopathy Market Size Share by Application (2014-2019) Figure Global Overt Hepatic Encephalopathy Market Size Market Share by Application (2014-2019) Figure Global Overt Hepatic Encephalopathy Revenue Market Share by Application in 2018 Figure United States Overt Hepatic Encephalopathy Market Size 2014-2019 (Million US$) Table United States Key Players Overt Hepatic Encephalopathy Revenue (2018-2019) (Million US$) Table United States Key Players Overt Hepatic Encephalopathy Market Share (2018-2019) Table United States Overt Hepatic Encephalopathy Market Size by Type (2014-2019) (Million US$) Table United States Overt Hepatic Encephalopathy Market Share by Type (2014-2019) Table United States Overt Hepatic Encephalopathy Market Size by Application (2014-2019) (Million US$) Table United States Overt Hepatic Encephalopathy Market Share by Application (2014-2019) Figure Europe Overt Hepatic Encephalopathy Market Size 2014-2019 (Million US$) Table Europe Key Players Overt Hepatic Encephalopathy Revenue (2018-2019) (Million US$) Table Europe Key Players Overt Hepatic Encephalopathy Market Share (2018-2019) Table Europe Overt Hepatic Encephalopathy Market Size by Type (2014-2019) (Million US$) Table Europe Overt Hepatic Encephalopathy Market Share by Type (2014-2019) Table Europe Overt Hepatic Encephalopathy Market Size by Application (2014-2019) (Million US$) Table Europe Overt Hepatic Encephalopathy Market Share by Application (2014-2019) Figure China Overt Hepatic Encephalopathy Market Size 2014-2019 (Million US$) Table China Key Players Overt Hepatic Encephalopathy Revenue (2018-2019) (Million US$) Table China Key Players Overt Hepatic Encephalopathy Market Share (2018-2019) Table China Overt Hepatic Encephalopathy Market Size by Type (2014-20189) (Million US$) Table China Overt Hepatic Encephalopathy Market Share by Type (2014-2019) Table China Overt Hepatic Encephalopathy Market Size by Application (2014-2019) (Million US$) Table China Overt Hepatic Encephalopathy Market Share by Application (2014-2019) Figure Japan Overt Hepatic Encephalopathy Market Size 2014-2019 (Million US$) Table Japan Key Players Overt Hepatic Encephalopathy Revenue (2018-2019) (Million US$) Table Japan Key Players Overt Hepatic Encephalopathy Market Share (2018-2019) Table Japan Overt Hepatic Encephalopathy Market Size by Type (2014-2019) (Million US$) Table Japan Overt Hepatic Encephalopathy Market Share by Type (2014-2019) Table Japan Overt Hepatic Encephalopathy Market Size by Application (2014-2019) (Million US$) Table Japan Overt Hepatic Encephalopathy Market Share by Application (2014-2019) Figure Southeast Asia Overt Hepatic Encephalopathy Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Overt Hepatic Encephalopathy Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Overt Hepatic Encephalopathy Market Share (2018-2019) Table Southeast Asia Overt Hepatic Encephalopathy Market Size by Type (2014-2019) (Million US$) Table Southeast Asia Overt Hepatic Encephalopathy Market Share by Type (2014-2019) Table Southeast Asia Overt Hepatic Encephalopathy Market Size by Application (2014-2019) (Million US$) Table Southeast Asia Overt Hepatic Encephalopathy Market Share by Application (2014-2019) Figure India Overt Hepatic Encephalopathy Market Size 2014-2019 (Million US$) Table India Key Players Overt Hepatic Encephalopathy Revenue (2018-2019) (Million US$) Table India Key Players Overt Hepatic Encephalopathy Market Share (2018-2019) Table India Overt Hepatic Encephalopathy Market Size by Type (2014-2019) (Million US$) Table India Overt Hepatic Encephalopathy Market Share by Type (2014-2019) Table India Overt Hepatic Encephalopathy Market Size by Application (2014-2019) (Million US$) Table India Overt Hepatic Encephalopathy Market Share by Application (2014-2019) Figure Central & South America Overt Hepatic Encephalopathy Market Size 2014-2019 (Million US$) Table Central & South America Key Players Overt Hepatic Encephalopathy Revenue (2018-2019) (Million US$) Table Central & South America Key Players Overt Hepatic Encephalopathy Market Share (2018-2019) Table Central & South America Overt Hepatic Encephalopathy Market Size by Type (2014-2019) (Million US$) Table Central & South America Overt Hepatic Encephalopathy Market Share by Type (2014-2019) Table Central & South America Overt Hepatic Encephalopathy Market Size by Application (2014-2019) (Million US$) Table Central & South America Overt Hepatic Encephalopathy Market Share by Application (2014-2019) Table Alfa Wassermann Company Details Table Alfa Wassermann Revenue in Overt Hepatic Encephalopathy Business (2014-2019) (Million US$) Figure Alfa Wassermann Revenue Growth Rate in Overt Hepatic Encephalopathy Business (2014-2019) Table Alfa Wassermann Recent Development Table Cosmo Pharmaceuticals Company Details Table Cosmo Pharmaceuticals Revenue in Overt Hepatic Encephalopathy Business (2014-2019)(Million US$) Figure Cosmo Pharmaceuticals Revenue Growth Rate in Overt Hepatic Encephalopathy Business (2014-2019) Table Cosmo Pharmaceuticals Recent Development Table Horizon Pharma Company Details Table Horizon Pharma Revenue in Overt Hepatic Encephalopathy Business (2014-2019)(Million US$) Figure Horizon Pharma Revenue Growth Rate in Overt Hepatic Encephalopathy Business (2014-2019) Table Horizon Pharma Recent Development Table KannaLife Sciences Company Details Table KannaLife Sciences Revenue in Overt Hepatic Encephalopathy Business (2014-2019)(Million US$) Figure KannaLife Sciences Revenue Growth Rate in Overt Hepatic Encephalopathy Business (2014-2019) Table KannaLife Sciences Recent Development Table Ocer Therapeutics Company Details Table Ocer Therapeutics Revenue in Overt Hepatic Encephalopathy Business (2014-2019)(Million US$) Figure Ocer Therapeutics Revenue Growth Rate in Overt Hepatic Encephalopathy Business (2014-2019) Table Ocer Therapeutics Recent Development Table Rebiotix Company Details Table Rebiotix Revenue in Overt Hepatic Encephalopathy Business (2014-2019)(Million US$) Figure Rebiotix Revenue Growth Rate in Overt Hepatic Encephalopathy Business (2014-2019) Table Rebiotix Recent Development Table Spherium Biomed Company Details Table Spherium Biomed Revenue in Overt Hepatic Encephalopathy Business (2014-2019)(Million US$) Figure Spherium Biomed Revenue Growth Rate in Overt Hepatic Encephalopathy Business (2014-2019) Table Spherium Biomed Recent Development Table Umecrine Cognition Company Details Table Umecrine Cognition Revenue in Overt Hepatic Encephalopathy Business (2014-2019)(Million US$) Figure Umecrine Cognition Revenue Growth Rate in Overt Hepatic Encephalopathy Business (2014-2019) Table Umecrine Cognition Recent Development Table ASKA Pharmaceutical Company Details Table ASKA Pharmaceutical Revenue in Overt Hepatic Encephalopathy Business (2014-2019)(Million US$) Figure ASKA Pharmaceutical Revenue Growth Rate in Overt Hepatic Encephalopathy Business (2014-2019) Table ASKA Pharmaceutical Recent Development Table Mallinckrodt Company Details Table Mallinckrodt Revenue in Overt Hepatic Encephalopathy Business (2014-2019)(Million US$) Figure Mallinckrodt Revenue Growth Rate in Overt Hepatic Encephalopathy Business (2014-2019) Table Mallinckrodt Recent Development Table Valeant Company Details Table Global Overt Hepatic Encephalopathy Market Size by Regions (Million US$) 2019-2025 Figure Global Overt Hepatic Encephalopathy Market Size Share by Regions (2019-2025) Figure Global Overt Hepatic Encephalopathy Market Size Share by Regions in 2025 Figure United States Overt Hepatic Encephalopathy Market Size Forecast (2019-2025)(Million USD) Figure Europe Overt Hepatic Encephalopathy Market Size Forecast (2019-2025)(Million USD) Figure China Overt Hepatic Encephalopathy Market Size Forecast (2019-2025)(Million USD) Figure Japan Overt Hepatic Encephalopathy Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Overt Hepatic Encephalopathy Market Size Forecast (2019-2025)(Million USD) Figure India Overt Hepatic Encephalopathy Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Overt Hepatic Encephalopathy Market Size Forecast (2019-2025)(Million USD) Table Global Overt Hepatic Encephalopathy Market Size by Product (2019-2025) (Million US$) Figure Global Overt Hepatic Encephalopathy Market Size by Product (2019-2025) Figure Global Overt Hepatic Encephalopathy Market Size by Product in 2025 Table Global Overt Hepatic Encephalopathy Market Size by Application (2019-2025) (Million US$) Figure Global Overt Hepatic Encephalopathy Market Size by Application (2019-2025) Figure Global Overt Hepatic Encephalopathy Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Alfa Wassermann Cosmo Pharmaceuticals Horizon Pharma KannaLife Sciences Ocer Therapeutics Rebiotix Spherium Biomed Umecrine Cognition ASKA Pharmaceutical Mallinckrodt Valeant